Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).

ClinicalTrials.gov ID: NCT03464019

Public ClinicalTrials.gov record NCT03464019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This was a three-part, multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etripamil nasal spray (NS) self-administered by participants who experienced an episode of paroxysmal supraventricular tachycardia (PSVT) in an at-home setting. NODE-301 Part 1 included participants that received the randomized study drug to treat an episode of PSVT until the 150th positively adjudicated PSVT episode. Part 2 (also referred as the RAPID study) included participants that did not receive the randomized study drug in Part 1 and newly enrolled participants until the 180th positively adjudicated PSVT episode in Part 2. The study continued for approximately 6 months after the 180th positively adjudicated PSVT episode in Part 2 and this extension is referred to as Part 3 (also referred to as RAPID Extension).

Study identification

NCT ID
NCT03464019
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
1,097 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2018 (Actual)
Primary completion
Jan 20, 2023 (Actual)
Completion
Jan 20, 2023 (Actual)
Last update posted
Jul 12, 2024

2018 – 2023

United States locations

U.S. sites
54
U.S. states
23
U.S. cities
47
Facility City State ZIP Site status
Arizona Arrhythmia Research Center Phoenix Arizona 85016 —
Arkansas Cardiology Little Rock Arkansas 72205 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Medvin Clinical Research Cerritos California 91722 —
North Coast Cardiolog Encinitas California 92024 —
Titan Medical Research - Oceanside Encinitas California 92024 —
Los Alamitos Cardiovascular Los Alamitos California 90720 —
Amicis Research Center - Northridge Northridge California 91324 —
RESPIRE Research Palm Springs California 92262 —
South Denver Cardiology Associates, P.C Littleton Colorado 80120 —
Cardiology Associates of Fairfield County Norwalk Connecticut 06905 —
FWD Clinical Research Boca Raton Florida 33486 —
Baptist Health Ambulatory Services d/b/a Jacksonville Florida 32207 —
United Health Research, LLC Miami Florida 33144 —
IACT Health Columbus Georgia 31904 —
Piedmont Heart Institute- Fayetteville Fayetteville Georgia 30214 —
Piedmont Heart Institute-Fayetteville Fayetteville Georgia 30309 —
Georgia Arrythmia Consultants&Research Institute Macon Georgia 31201 —
St. Luke's Idaho Cardiology Associates Boise Idaho 83702 —
Idaho Catalyst Clinical Research Idaho Falls Idaho 83404 —
AMITA Health Medical Group Heart & Vascular Elk Grpve Village Elk Grove Village Illinois 60007 —
Parkview Physicians Group - Cardiology Fort Wayne Indiana 46845 —
Mercy One Iowa Heart Center West Des Moines Iowa 50266 —
Clinical Trials of America, LLC - Monroe, LA West Monroe Louisiana 71291 —
MedStar Health Research Institute - Chesapeake Cardiovascular Associates Baltimore Maryland 21237 —
Sparrow Clinical Research Institute Lansing Michigan 48912 —
Revival Research Institute, LLC - Southgate, MI Southgate Michigan 48195 —
Mercy Research St Louis Missouri 65804 —
Cardiovascular Associates of the Delaware Valley - Elmer Elmer New Jersey 08318 —
Cardiovascular Associates of the Delaware Valley Haddon Heights New Jersey 08035 —
Atlantic Health System - Morristown Medical Center Morristown New Jersey 07962 —
Columbia University New York New York 10032 —
New York Presbyterian Hospital/Weill Cornell Medical Center New York New York 10065 —
Montefiore Medical Center The Bronx New York 10467 —
Cary Research Group, LLC Cary North Carolina 27518 —
Sanger Heart and Vascular Institute Charlotte North Carolina 28204 —
The Presbyterian Hospital DBA Novant Health Heart and Vascular Institute Charlotte North Carolina 28204 —
Hatton Institute for Research & Education, Trihealth, Inc. - Cardiology Cincinnati Ohio 45242 —
The Ohio State University (OSU) Wexner Medical Center Columbus Ohio 43210 —
Rama Research LLC Marion Ohio 43302 —
Heart House Research Foundation, LLC Springfield Ohio 45505 —
ProMedica Toledo Hospital Toledo Ohio 43615 —
Medical University of South Carolina (MUSC) Charleston South Carolina 29425 —
Prisma Health Midlands Columbia South Carolina 29203 —
Monument Health Clinical Research, a department of Monument Health Rapid City Hospital, Inc Rapid City South Dakota 57701 —
North Texas Research Associates Allen Texas 75013 —
Cardiovascular Clinic of North Texas Denton Texas 76201 —
Revival Research Institute, LLC Denton Texas 76201 —
Apex Trials Group Fort Worth Texas 76104 —
Angiocardiac Care of Texas Houston Texas 77025 —
Baylor College of Medicine Houston Texas 77030 —
Scott & White Memorial Hospital: Baylor Scott & White Research Institute Temple Texas 76508 —
Bay Area Heart Webster Texas 77598 —
Intermountain Medical Center Murray Utah 84157-7000 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 107 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03464019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2024 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03464019 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →